- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutics for flaviviral infections
Authors
Keywords
-
Journal
ANTIVIRAL RESEARCH
Volume 210, Issue -, Pages 105517
Publisher
Elsevier BV
Online
2022-12-31
DOI
10.1016/j.antiviral.2022.105517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model
- (2022) Kai Lin et al. PLoS Neglected Tropical Diseases
- Mouse models of Japanese encephalitis virus infection: A systematic review and meta-analysis using a meta-regression approach
- (2022) Tehmina Bharucha et al. PLoS Neglected Tropical Diseases
- A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response
- (2022) Zhao Gao et al. PLoS Pathogens
- Flavivirus NS4B protein: Structure, function, and antiviral discovery
- (2022) Yan Wang et al. ANTIVIRAL RESEARCH
- Evolution of inflammation and immunity in a dengue virus 1 human infection model
- (2022) Adam T. Waickman et al. Science Translational Medicine
- A broadly protective antibody that targets the flavivirus NS1 protein
- (2021) Naphak Modhiran et al. SCIENCE
- Structural basis for antibody inhibition of flavivirus NS1–triggered endothelial dysfunction
- (2021) Scott B. Biering et al. SCIENCE
- Synthesis, Structure–Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B–NS3 Protease
- (2021) Shenyou Nie et al. JOURNAL OF MEDICINAL CHEMISTRY
- NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models
- (2021) Stephanie A. Moquin et al. Science Translational Medicine
- Identification and Characterization of Zika Virus NS5 Methyltransferase Inhibitors
- (2021) Weibao Song et al. Frontiers in Cellular and Infection Microbiology
- Evaluation of AT-752, a double prodrug of a guanosine nucleotide analog with in vitro and in vivo activity against dengue and other flaviviruses
- (2021) Steven S. Good et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors
- (2021) Dario Akaberi et al. ANTIVIRAL RESEARCH
- Human inducible pluripotent stem cells: Realization of initial promise in drug discovery
- (2021) Robin J. Kleiman et al. Cell Stem Cell
- Effect of immature tick-borne encephalitis virus particles on antiviral activity of 5-aminoisoxazole-3-carboxylic acid adamantylmethyl esters
- (2021) Ksenia K. Tuchynskaya et al. JOURNAL OF GENERAL VIROLOGY
- The compound SBI-0090799 inhibits Zika virus (ZIKV) infection by blocking de novo formation of the membranous replication compartment
- (2021) Laura Riva et al. JOURNAL OF VIROLOGY
- Dengue Detection: Advances in Diagnostic Tools from Conventional Technology to Point of Care
- (2021) Md Alamgir Kabir et al. Biosensors-Basel
- SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases
- (2021) Hannah Maus et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)
- (2021) Luis Rivera et al. CLINICAL INFECTIOUS DISEASES
- Amidoxime prodrugs convert to potent cell-active multimodal inhibitors of the dengue virus protease
- (2021) Crystall Swarbrick et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease
- (2021) Shenyou Nie et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction
- (2021) Suzanne J. F. Kaptein et al. NATURE
- A conserved arginine in NS5 binds genomic 3′ stem–loop RNA for primer-independent initiation of flavivirus RNA replication
- (2021) Sai Wang et al. RNA
- In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
- (2021) Zhong Li et al. Acta Pharmaceutica Sinica B
- Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro
- (2020) Filippo Dragoni et al. ANTIVIRAL RESEARCH
- Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase
- (2020) Rolando Cannalire et al. ACS Medicinal Chemistry Letters
- A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine
- (2020) Milly M. Choy et al. Cell Reports
- The continued threat of emerging flaviviruses
- (2020) Theodore C. Pierson et al. Nature Microbiology
- FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells
- (2020) Michal Stefanik et al. Microorganisms
- Conformational selection in the flaviviral NS2B-NS3 protease
- (2020) Mira A.M. Behnam et al. BIOCHIMIE
- A Phase 1, Open Label- Assessment of a Dengue Virus-1 Live Virus Human Challenge - (DENV-1-LVHC) Strain
- (2020) Timothy P Endy et al. JOURNAL OF INFECTIOUS DISEASES
- Recent advances in antiviral drug development towards dengue virus
- (2020) Berit Troost et al. Current Opinion in Virology
- Interference of dengue replication by blocking the access of 3′ SL RNA to the viral RNA-dependent RNA polymerase
- (2020) Chairat Tunghirun et al. ANTIVIRAL RESEARCH
- Two RNA tunnel inhibitors bind in highly conserved sites in Dengue virus NS5 polymerase: structural and functional studies
- (2020) Rishi Arora et al. JOURNAL OF VIROLOGY
- Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial
- (2020) Yupin Suputtamongkol et al. CLINICAL INFECTIOUS DISEASES
- Immortalized stem cell-derived hepatocyte-like cells: An alternative model for studying dengue pathogenesis and therapy
- (2020) Kessiri Kongmanas et al. PLoS Neglected Tropical Diseases
- Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo
- (2019) Pi-Chun Li et al. ACS Infectious Diseases
- Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
- (2019) Caroline S. de Freitas et al. PLoS Neglected Tropical Diseases
- Phylogenetically based establishment of a dengue virus panel, representing all available genotypes, as a tool in dengue drug discovery
- (2019) Franck Touret et al. ANTIVIRAL RESEARCH
- Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease
- (2019) Yuan Yao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
- (2019) Mark J. Bailey et al. mBio
- Design, Synthesis, and Biological Evaluation of Substituted 4,6-Dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione Analogues as Potent NS4B Inhibitors for the Treatment of Dengue Virus Infection
- (2019) Jimin Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- An RNA-centric dissection of host complexes controlling flavivirus infection
- (2019) Yaw Shin Ooi et al. Nature Microbiology
- Antiviral activity of ST081006 against the dengue virus
- (2019) Jing Kai Lee et al. ANTIVIRAL RESEARCH
- Inflammatory responses to a pathogenic West Nile virus strain
- (2019) Bixing Huang et al. BMC INFECTIOUS DISEASES
- Dengue NS2A Protein Orchestrates Virus Assembly
- (2019) Xuping Xie et al. Cell Host & Microbe
- Modelling Neurotropic Flavivirus Infection in Human Induced Pluripotent Stem Cell-Derived Systems
- (2019) Giovanna Desole et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Zika Virus NS2A-Mediated Virion Assembly
- (2019) Xianwen Zhang et al. mBio
- A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses
- (2019) Chi-Chen Yang et al. ANTIVIRAL RESEARCH
- Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening
- (2018) Aryamav Pattnaik et al. ANTIVIRAL RESEARCH
- Characterization and structure-activity relationship analysis of a class of antiviral compounds that directly bind dengue virus capsid protein and are incorporated into virions
- (2018) Jessica L. Smith et al. ANTIVIRAL RESEARCH
- Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A
- (2018) Haruaki Nobori et al. ANTIVIRAL RESEARCH
- Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease
- (2018) Zhong Li et al. ANTIVIRAL RESEARCH
- Preclinical Antiviral Testing for Dengue Virus Infection in Mouse Models and Its Association with Clinical Studies
- (2018) Satoru Watanabe et al. ACS Infectious Diseases
- The emergence of Zika virus and its new clinical syndromes
- (2018) Theodore C. Pierson et al. NATURE
- Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
- (2018) Mark J. Bailey et al. Nature Communications
- Current Status of Dengue Therapeutics Research and Development
- (2017) Jenny G. H. Low et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical and laboratory factors associated with mortality in dengue
- (2017) Atul Saroch et al. TROPICAL DOCTOR
- Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age
- (2017) Scott B. Halstead VACCINE
- Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy
- (2016) Satoru Watanabe et al. ANTIVIRAL RESEARCH
- Quantifying the Epidemiological Impact of Vector Control on Dengue
- (2016) Robert C. Reiner et al. PLoS Neglected Tropical Diseases
- Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling
- (2016) Siew Pheng Lim et al. PLoS Pathogens
- Targeting dengue virus NS4B protein for drug discovery
- (2015) Xuping Xie et al. ANTIVIRAL RESEARCH
- The dengue virus NS5 protein as a target for drug discovery
- (2015) Siew Pheng Lim et al. ANTIVIRAL RESEARCH
- Animal models for studying dengue pathogenesis and therapy
- (2015) Kitti Wing Ki Chan et al. ANTIVIRAL RESEARCH
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
- (2015) P. Robert Beatty et al. Science Translational Medicine
- Dengue Virus Non-structural Protein 1 Modulates Infectious Particle Production via Interaction with the Structural Proteins
- (2015) Pietro Scaturro et al. PLoS Pathogens
- Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial
- (2014) Jenny G Low et al. LANCET INFECTIOUS DISEASES
- Flavivirus NS1 Structures Reveal Surfaces for Associations with Membranes and the Immune System
- (2014) D. L. Akey et al. SCIENCE
- Dengue Therapeutics, Chemoprophylaxis, and Allied Tools: State of the Art and Future Directions
- (2014) James Whitehorn et al. PLoS Neglected Tropical Diseases
- Ten years of dengue drug discovery: Progress and prospects
- (2013) Siew Pheng Lim et al. ANTIVIRAL RESEARCH
- Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir
- (2013) Y.-L. Chen et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- West Nile Virus in the United States — A Historical Perspective
- (2013) John Roehrig Viruses-Basel
- Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial
- (2012) Satoru Watanabe et al. ANTIVIRAL RESEARCH
- A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
- (2012) Nguyet Minh Nguyen, Chau Nguyen Bich Tran, Lam Khanh Phung, Kien Thi Hue Duong, Huy le Anh Huynh, Jeremy Farrar, Quyen Than Ha Nguyen, Hien Tinh Tran, Chau Van Vinh Nguyen, Laura Merson, Long Truong Hoang, Martin L. Hibberd, Pauline P. K. Aw, Andreas Wilm, Niranjan Nagarajan, Dung Thi Nguyen et al. JOURNAL OF INFECTIOUS DISEASES
- Dengue
- (2012) Cameron P. Simmons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
- (2011) Mark E. Beatty et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model
- (2011) Abhay P.S. Rathore et al. ANTIVIRAL RESEARCH
- Inhibition of Dengue Virus by Targeting Viral NS4B Protein
- (2011) X. Xie et al. JOURNAL OF VIROLOGY
- Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection
- (2011) Dongmei Hu et al. Virology Journal
- The Early Clinical Features of Dengue in Adults: Challenges for Early Clinical Diagnosis
- (2011) Jenny G. H. Low et al. PLoS Neglected Tropical Diseases
- West Nile Virus Differentially Modulates the Unfolded Protein Response To Facilitate Replication and Immune Evasion
- (2010) R. L. Ambrose et al. JOURNAL OF VIROLOGY
- An adenosine nucleoside inhibitor of dengue virus
- (2009) Z. Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure
- (2009) M. Issur et al. RNA
- Flavivirus methyltransferase: A novel antiviral target
- (2008) Hongping Dong et al. ANTIVIRAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started